Kendall Capital Management Takes Position in Adtalem Global Education Inc. $CVSA

Kendall Capital Management bought a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000.

Adtalem Global Education Stock Performance

Adtalem Global Education stock opened at $132.55 on Friday. The firm has a market cap of $4.51 billion, a price-to-earnings ratio of 18.83, a PEG ratio of 0.98 and a beta of 0.62. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The business’s 50 day moving average is $125.54. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.19. The company had revenue of $501.38 million during the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, analysts forecast that Adtalem Global Education Inc. will post 9 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Robert J. Phelan sold 2,900 shares of the company’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $135.41, for a total value of $392,689.00. Following the completion of the transaction, the chief financial officer directly owned 52,906 shares in the company, valued at approximately $7,164,001.46. This represents a 5.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 3,545 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $130.34, for a total transaction of $462,055.30. Following the sale, the chief executive officer directly owned 415,197 shares of the company’s stock, valued at approximately $54,116,776.98. The trade was a 0.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 25,951 shares of company stock worth $3,470,783. 2.50% of the stock is currently owned by company insiders.

Key Headlines Impacting Adtalem Global Education

Here are the key news stories impacting Adtalem Global Education this week:

• Positive Sentiment: Zacks Research introduced a FY2029 EPS estimate of $11.53, indicating expected earnings growth from its $8.99 current-year consensus estimate. Its FY2028 forecast of $9.94 also remains above the current-year outlook.
• Neutral Sentiment: The revisions came from Zacks Research and do not represent a change to the broader consensus estimate for Adtalem’s current fiscal year, which remains $8.99 per share.
• Negative Sentiment: Zacks reduced EPS forecasts across multiple periods: Q1 2027 to $1.97 from $2.00, Q2 2027 to $2.38 from $2.51, Q4 2027 to $2.28 from $2.29, Q1 2028 to $2.30 from $2.33, Q2 2028 to $2.56 from $2.68, Q3 2028 to $2.50 from $2.53, and Q4 2028 to $2.59 from $2.63. Zacks also lowered its FY2028 forecast to $9.94 from $10.16, signaling somewhat softer projected profitability.

Wall Street Analyst Weigh In

CVSA has been the topic of several research reports. Barrington Research restated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Wednesday. Finally, Truist Financial lifted their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.